Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection Images

Generic Name: ranibizumab

This medication has been identified as Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection. It is supplied by Biogen.

Byooviz is used in the treatment of Macular Degeneration; Macular Edema Following Retinal Vein Occlusion; Myopic Choroidal Neovascularization; Macular Edema and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Byooviz 0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Byooviz

Generic Name

ranibizumab

Strength

0.5 mg (0.05 mL of 10 mg/mL solution) intravitreal injection

Availability

Prescription only

Drug Class

Anti-angiogenic ophthalmic agents

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Biogen

National Drug Code (NDC)

64406-0019

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer